The multiplexing capability of the UltraSEEK® chemistry makes it easy to detect over 100 variants, including insertions and deletions, using cfDNA from a single blood draw.
Learn MoreThe VeriDose Core Panel targets the most relevant variants in 20 principle genes implicated in drug metabolism pathways. It provides genotype information for 68 SNPs/INDELs across 20 genes. The panel is designed to be tolerant to low quality DNA, boosting the likelihood of success with challenging samples.
Learn MoreDate: October 23, 2024 - October 25, 2024
Location: Sydney, Australia
Date: November 19, 2024 - November 23, 2024
Location: Vancouver, Canada
29 November 2021
14 September 2021